ReviewDiagnostics (Basel, Switzerland)2022

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer-An Opportunity for Targeted Therapy.

Laura M Harbin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.